AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$NEOG

NEOGEN CORP

Price · $NEOGvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $NEOG in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $NEOG in the last 30 days.

Top stories · $NEOGMore →
MAY 3·IndexBoxMed

StockStory Analysis: Wynn Resorts and Neogen to Sell, Bowhead Specialty to Buy - News and Statistics

A recent StockStory analysis evaluates three companies receiving significant attention from Wall Street, cautioning against overly optimistic price targets from analysts. The report recommends selling Wynn Resorts and Neogen based on revenue growth, free cash flow, debt ratios, and market challenges. Conversely, Bowhead Specialty Holdings is identified as a stock likely to meet or exceed expectations due to its strong market position.

MAR 12·StockStory

Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

This article analyzes the Q4 earnings performance of Abbott Laboratories (NYSE:ABT) and other diversified medical device and supplies companies. Abbott Laboratories reported revenues that missed analyst expectations by 2.9% and saw its stock fall 9.6%. In contrast, Neogen (NASDAQ:NEOG) achieved the strongest performance, beating revenue estimates by 7.2% and seeing its stock rise 33.8%.

FEB 25·Finviz - Stock Screener

Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

This article reviews the Q4 earnings performance of Boston Scientific (NYSE:BSX) and other diversified medical devices and supplies companies. It highlights that the industry faces both tailwinds like aging populations and digital health advancements, and headwinds such as pricing pressures and cybersecurity concerns. While Boston Scientific saw strong revenue growth, Neogen (NASDAQ:NEOG) achieved the biggest analyst estimates beat, and Abbott Laboratories (NYSE:ABT) showed the weakest performance against estimates.

News on $NEOG

All news →